Congressional Stock Trades & Disclosures
Ron Wyden is a U.S. Senator, a Democrat representing OR. As of July 2025, Bullish Whales has tracked 299 disclosed stock trades across 66 companies, representing $13.4M in disclosed transaction value, each filed publicly under the STOCK Act.
About Wyden's congressional trading
Wyden's disclosed activity shows a buy-leaning pattern, with 237 purchases and 62 sales (a buy-to-sell ratio of 3.82). Wyden has traded --, AAPL, and KLAC most frequently among disclosed positions.
Wyden's most recent disclosed trade was a sale of Pfizer Inc (PFE) from June 2025. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Estimated trading profits
No priced buy disclosures in this window.
No priced buy disclosures in this window.
Based on 231 of 250 disclosed buys with pricing coverage.
Apr 6, 2020 to Jul 14, 2026
Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.
Disclosed trades & legislation
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
 PFEPfizer Inc | Sell | $1,001 - $15,000 | 03 JUN 2025 | $21.82 | +11.11% |
 LLYEli Lilly and Company | Sell | $50,001 - $100,000 | 10 FEB 2025 | $859.53 | +34.09% |
 IRBTiRobot Corporation | Sell | $1,001 - $15,000 | 06 FEB 2025 | N/A | — |
 SOLVSolventum Corp. | Sell | $1,001 - $15,000 | 06 FEB 2025 | $74.78 | +2.01% |
| LLYEli Lilly and Company | Buy | $50,001 - $100,000 | 22 JAN 2025 | $745.87 | +54.52% |
 UPSUnited Parcel Service Inc | Sell | $100,001 - $250,000 | 27 MAR 2024 | $128.98 | -11.87% |
 --JTKWY - Just Eat Takeaway.com NV - ADR | Sell | $1,001 - $15,000 | 11 NOV 2022 | N/A | — |
 METAMeta Platforms Inc. | Sell | $50,001 - $100,000 | 11 NOV 2022 | $112.14 | +489.48% |
 MMM3M Company | Sell | $1,001 - $15,000 | 11 NOV 2022 | $97.36 | +60.82% |
 STXSeagate Technology PLC | Sell | $15,001 - $50,000 | 11 NOV 2022 | $51.43 | +1607.86% |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Ron Wyden congressional trading FAQ
Can Ron Wyden legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Ron Wyden's disclosures so the public can review them.
Where does Quantellect get Ron Wyden's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Ron Wyden's stock trades?
Quantellect tracks every stock trade Ron Wyden discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Ron Wyden disclosed?
Quantellect has tracked 299 disclosed trades by Ron Wyden across 66 companies.
Which stocks does Ron Wyden trade most?
Ron Wyden's most frequently disclosed positions include --, AAPL, KLAC, NVDA, and DIS. The full list of companies and individual filings is shown on this page.
What was Ron Wyden's most recent stock trade?
Ron Wyden most recently sold Pfizer Inc (PFE) in June 2025, according to public STOCK Act filings tracked by Quantellect.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.